Stock Scorer

Lavipharm S.A (LAVI.AT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in EUR. Every figure as a table ›

Revenue Annual

0 25M 50M 75M FY21: 39.7M FY22: 39.1M FY23: 47.8M FY24: 52.9M FY25: 62.6M FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 15M 30M 45M FY21: 15.9M FY22: 17.6M FY23: 22.1M FY24: 25.1M FY25: 30.3M FY21 FY22 FY23 FY24 FY25

Operating Income Annual

0 3.5M 7M 10.5M FY21: 4.6M FY22: 3.9M FY23: 5.2M FY24: 5.5M FY25: 9.3M FY21 FY22 FY23 FY24 FY25

Net Income Annual

0 3.5M 7M 10.5M FY21: 1.7M FY22: 830K FY23: 1.9M FY24: 9M FY25: 6M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 15M 30M 45M FY21: 23.8M FY22: 21.4M FY23: 25.7M FY24: 27.9M FY25: 32.3M FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

0 2.5M 5M 7.5M FY21: 4.1M FY22: 3.3M FY23: 284K FY24: 4.6M FY25: 6.7M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY21: 2.2M FY22: -32.3M FY23: -3.8M FY24: -5M FY25: 2M FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Not drawn for LAVI.AT: Shares Outstanding, EPS. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.